72 related articles for article (PubMed ID: 25329108)
21. The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved.
Guardado-Estrada M; Medina-Martínez I; Juárez-Torres E; Roman-Bassaure E; Macías L; Alfaro A; Alcántara-Vázquez A; Alonso P; Gomez G; Cruz-Talonia F; Serna L; Muñoz-Cortez S; Borges-Ibañez M; Espinosa A; Kofman S; Berumen J
J Hum Genet; 2012 Apr; 57(4):269-76. PubMed ID: 22357541
[TBL] [Abstract][Full Text] [Related]
22. [Significance of pelvic lymph node human papillomavirus DNA detection in cervical cancer].
Liu GB; Liu X; Pang ZJ; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1236-9. PubMed ID: 16234097
[TBL] [Abstract][Full Text] [Related]
23. Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma.
Ikuta A; Saito J; Mizokami T; Nakamoto T; Yasuhara M; Nagata F; Nakajima M; Matsuo I; Yasuda K; Kanzaki H
Cancer Detect Prev; 2005; 29(6):528-36. PubMed ID: 16289387
[TBL] [Abstract][Full Text] [Related]
24. Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells.
Vermeulen CF; Jordanova ES; Szuhai K; Kolkman-Uljee S; Vrede MA; Peters AA; Schuuring E; Fleuren GJ
Cancer Genet Cytogenet; 2007 Jun; 175(2):132-7. PubMed ID: 17556069
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
26. Detection of HPV16 and 18 by in situ hybridization in precancerous and cancerous lesions of cervix.
Choudhury M; Singh S
Indian J Pathol Microbiol; 2006 Jul; 49(3):345-7. PubMed ID: 17001881
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma.
Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B
Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554
[TBL] [Abstract][Full Text] [Related]
28. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
29. [Infection with high-risk human papillomavirus and prognosis of cervical carcinoma].
Kiseleva VI; Krikunova LI; Liubina LV; Beziaeva GP; Panarina LV; Iurochkina NI; Kuevda DA; Shipulina OIu; Saenko AS
Vopr Onkol; 2010; 56(2):185-90. PubMed ID: 20552895
[TBL] [Abstract][Full Text] [Related]
30. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
[TBL] [Abstract][Full Text] [Related]
32. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
33. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.
de Vos van Steenwijk PJ; Heusinkveld M; Ramwadhdoebe TH; Löwik MJ; van der Hulst JM; Goedemans R; Piersma SJ; Kenter GG; van der Burg SH
Cancer Res; 2010 Apr; 70(7):2707-17. PubMed ID: 20233872
[TBL] [Abstract][Full Text] [Related]
34. HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.
Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
Gynecol Oncol; 2011 Jun; 121(3):546-50. PubMed ID: 21334052
[TBL] [Abstract][Full Text] [Related]
35. Gene identification by cDNA arrays in HPV-positive cervical cancer.
Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M
Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
Zehbe I; Kaufmann AM; Schmidt M; Hohn H; Maeurer MJ
J Immunother; 2007; 30(5):523-32. PubMed ID: 17589293
[TBL] [Abstract][Full Text] [Related]
37. HPV status and its genomic integration affect survival of patients with cervical cancer.
Ibragimova M; Tsyganov M; Shpileva O; Churuksaeva O; Bychkov V; Kolomiets L; Litviakov N
Neoplasma; 2018 Mar; 65(3):441-448. PubMed ID: 29788735
[TBL] [Abstract][Full Text] [Related]
38. Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer.
Xia Q; Jin H; Zhang X; Yan W; Meng D; Ding B; Cao J; Li D; Wang S
Int Immunopharmacol; 2020 Nov; 88():106935. PubMed ID: 32889244
[TBL] [Abstract][Full Text] [Related]
39. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.
Punt S; Corver WE; van der Zeeuw SA; Kielbasa SM; Osse EM; Buermans HP; de Kroon CD; Jordanova ES; Gorter A
Oncotarget; 2015 Nov; 6(36):38681-94. PubMed ID: 26299617
[TBL] [Abstract][Full Text] [Related]
40. HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.
Mkrtchian L; Zamulaeva I; Krikunova L; Kiseleva V; Matchuk O; Liubina L; Kulieva G; Ivanov S; Kaprin A
J Pers Med; 2021 May; 11(6):. PubMed ID: 34071821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
